| Device type | Drug-eluting stent | Drug-eluting stent | Drug-eluting stent |
| Drug coating | Sirolimus | Sirolimus | Everolimus |
| Material | L605 cobalt-chromium alloy | L605 cobalt-chromium alloy | L605 cobalt-chromium alloy |
| Diameter, mm | 2.00–4.50 | 2.25–4.00 | 2.25–5.00 |
| Length, mm | 8–48 | 10–48 | 8–48 |
| Sizes in the range | 107 | 72 | 128 |
| Nominal pressure (NP) | Ø 2.00–2.50 mm — 11 atm; Ø 2.75–3.50 mm — 10 atm; Ø 4.00–4.50 mm — 9 atm | 8 atm | 8 atm |
| Rated burst pressure (RBP) | 16 atm | 16 atm | Ø 2.25–4.00 mm: 16 atm; Ø 4.50–5.00 mm: 14 atm |
| Guidewire compatibility | 0.014″ | max 0.014″ | max 0.014″ |
| Guiding catheter compatibility | 5F minimum | 5F | 5F (Ø up to 4.00 mm); 6F (Ø 4.50–5.00 mm) |
| Radiopaque markers | Pt-Ir | Pt-Ir, 2 pcs; 0.80 ± 0.05 mm | Pt-Ir, 2 pcs; 0.80 ± 0.05 mm |
| Usable catheter length | 142 cm | 1414 ± 50 mm | 1414 ± 50 mm |
| Inflation / deflation time | 3 s | — | — |
| Catheter coating | Hydrophilic, Hydrax | — | — |
| Balloon material | — | Polyamide | Polyamide |
| Strut thickness | — | 0.0625 ± 0.0075 mm (Ø 2.25–3.50 mm); 0.0650 ± 0.0075 mm (Ø 4.00 mm) | 0.0625 ± 0.0075 mm (Ø 2.25–3.50 mm); 0.0650 ± 0.0075 mm (Ø 4.00–5.00 mm) |
| Delivery system outer diameter | — | 0.57–1.40 mm | 0.57–1.40 mm |
| Working diameter range | — | D × 0.90 to D × 1.05 (D = nominal diameter) | D × 0.90 to D × 1.05 (D = nominal diameter) |
| Coating polymer | — | Lactide-based polymer blend | Lactide-based polymer blend |
| Drug load | — | 39.6–373.2 µg sirolimus depending on size (±10%) | 28.8–373.2 µg everolimus depending on size (±10%) |
| MRI | — | MR conditional: up to 3 T, spatial gradient up to 720 G/cm, SAR up to 3.0 W/kg for 15 min | MR conditional: up to 3 T, spatial gradient up to 720 G/cm, SAR up to 3.0 W/kg for 15 min |
| Registration certificate | РЗН 2020/12264 dated 09.10.2020 | РЗН 2025/25737 dated 30.06.2025 | РЗН 2025/25736 dated 24.06.2025 |